MG

Meenal Gauri

Active Director Managing Director DIN 11421321
DIN 11421321 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Meenal Gauri

Data last updated:

Meenal Gauri is a Managing Director at Boehringer Ingelheim India Private Limited (since 2026). The company operates in Pharma.

DIN 11421321
Primary Designation Managing Director
Industry Pharma
First Appointment 12 Jan 2026
Oldest Company Age 22 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director12 Jan 20262003Active

Directorship timeline

Open interactive timeline →
Boehringer Ingelheim India Private Limited
Premium access

Shareholding and investment profile for Meenal Gauri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenal Gauri

Meenal Gauri currently holds 1 directorship: Boehringer Ingelheim India Private Limited (Managing Director, since 12 Jan 2026).

Meenal Gauri was first appointed on 12 Jan 2026 as Managing Director at Boehringer Ingelheim India Private Limited.

The current boards of Meenal Gauri's companies include Sandipkumar Rameshchandra Agrawal (Boehringer Ingelheim India Private Limited), Sanjay Srivastava (Boehringer Ingelheim India Private Limited), Shriya Mandar Oak (Boehringer Ingelheim India Private Limited), Vinod Gopal (Boehringer Ingelheim India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available